Miniaturized Cultivation of Microbiota for Antimalarial Drug Discovery |
|
Molecular characteristics of diffuse large B-cell lymphoma in human immunodeficiency virus-infected and -uninfected patients in the pre-highly active antiretroviral therapy and pre-rituximab era. |
|
Mutual Risks of Cutaneous Melanoma and Specific Lymphoid Neoplasms: Second Cancer Occurrence and Survival. |
|
No Association between Radiation Dose from Pediatric CT Scans and Risk of Subsequent Hodgkin Lymphoma |
|
A NOVEL METHOD TO ESTIMATE LYMPHOCYTE DOSE AND APPLICATION TO PEDIATRIC AND YOUNG ADULT CT PATIENTS IN THE UNITED KINGDOM. |
|
Patterns of Cause-Specific Mortality Among 2053 Survivors of Retinoblastoma, 1914-2016 |
|
Plasmodium falciparum Drug-Resistant Haplotypes and Population Structure in Postearthquake Haiti, 2010. |
|
Polycyclic aromatic hydrocarbons: determinants of residential carpet dust levels and risk of non-Hodgkin lymphoma |
|
Pooling prospective studies to investigate the etiology of second cancers |
|
Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies |
|
Prediction of the location and size of the stomach using patient characteristics for retrospective radiation dose estimation following radiotherapy |
|
Prevalence of HIV Infection among U.S. Hodgkin lymphoma cases |
|
Prevalence of pathogenic/likely pathogenic variants in the 24 cancer genes of the ACMG Secondary Findings v2.0 list in a large cancer cohort and ethnicity-matched controls |
|
Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival |
|
Proportions of Kaposi sarcoma, selected non-Hodgkin lymphomas, and cervical cancer in the United States occurring in persons with AIDS, 1980-2007. |
|
A prospective investigation of serum 25-hydroxyvitamin D and risk of lymphoid cancers |
|
Radiation dose to the esophagus from breast cancer radiation therapy, 1943-1996: an international population-based study of 414 patients |
|
Radiotherapy for ductal carcinoma in situ and risk of second non-breast cancers |
|
Rationale and Design of the International Lymphoma Epidemiology Consortium (InterLymph) Non-Hodgkin Lymphoma Subtypes Project |
|
Re: No increased risk of non-Hodgkin's lymphoma with steroids, estrogens and psychotropics (Netherlands) |
|
RE: The Association of Dyslipidemia With Chronic Lymphocytic Leukemia: A Population-Based Study. |
|
Recommendations for long-term follow-up of adults with heritable retinoblastoma |
|
Reply to "no robust evidence of lumefantrine resistance". |
|
Reporting participation in epidemiologic studies: a survey of practice |
|
Reproductive factors, exogenous hormone use and risk of lymphoid neoplasms among women in the National Institutes of Health-AARP Diet and Health Study Cohort |
|
The rising incidence of second cancers: patterns of occurrence and identification of risk factors for children and adults |
|
Risk factors for early-onset and late-onset post-transplant lymphoproliferative disorder in kidney recipients in the United States |
|
Risk factors for second acute myeloid leukemia/myelodysplastic syndrome among survivors of non-Hodgkin lymphoma. |
|
Risk factors for the development of cutaneous melanoma after allogeneic hematopoietic cell transplantation |
|
Risk for malignancies of infectious etiology among adult survivors of specific non-Hodgkin lymphoma subtypes |
|
Risk of diffuse large B-cell lymphoma after solid organ transplantation in the United States |
|
Risk of non-Hodgkin lymphoma subtypes in HIV-infected people during the HAART era: a population-based study |
|
Risk of rare cancers among solid organ transplant recipients |
|
Risk of second cancers according to radiation therapy technique and modality in prostate cancer survivors |
|
Risk of Second Primary Bone and Soft-Tissue Sarcomas Among Young Adulthood Cancer Survivors |
|
Risk of subsequent malignant neoplasms in long-term hereditary retinoblastoma survivors after chemotherapy and radiotherapy |
|
Risk of subsequent myeloid neoplasms after radiotherapy treatment for a solid cancer among adults in the United States, 2000-2014 |
|
Risk of therapy-related myelodysplastic syndrome/acute myeloid leukemia after childhood cancer: a population-based study |
|
Risk of treatment-related esophageal cancer among breast cancer survivors |
|
Robust Algorithm for Systematic Classification of Malaria Late Treatment Failures as Recrudescence or Reinfection Using Microsatellite Genotyping |
|
Role of Radiotherapy and Chemotherapy in the Risk of Leukemia after Childhood Cancer: An International Pooled Analysis |
|
Screening mangrove endophytic fungi for antimalarial natural products |
|
Selection and spread of artemisinin-resistant alleles in Thailand prior to the global artemisinin resistance containment campaign |
|
Sex- and subtype-specific analysis of H2AFX polymorphisms in non-Hodgkin lymphoma |
|
Sex-Related Effect on Immunotherapy Response: Implications and Opportunities |
|
Shedding light on UVR and Hodgkin lymphoma |
|
SLC6A3 and body mass index in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial |
|
Smoking, alcohol use, obesity, and overall survival from non-Hodgkin lymphoma: a population-based study |
|
Spatial-temporal analysis of non-Hodgkin lymphoma in the NCI-SEER NHL case-control study. |
|
A step toward slaying the hydra of second cancers |
|
Stomach Cancer Following Hodgkin Lymphoma, Testicular Cancer and Cervical Cancer: A Pooled Analysis of Three International Studies with a Focus on Radiation Effects |
|
Stomach cancer risk after treatment for hodgkin lymphoma |
|
Subsequent Primary Neoplasms: Risks, Risk Factors, Surveillance, and Future Research |
|
Subtype-specific incidence rates of lymphoid malignancies in Hong Kong compared to the United States, 2001-2010. |
|
Successful use of whole genome amplified DNA from multiple source types for high-density Illumina SNP microarrays. |
|
Telomere length-associated genetic variants and the risk of thyroid cancer in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study (CCSS) |
|
Testicular Cancer as a Model for Understanding the Impact of Evolving Treatment Strategies on the Long-Term Health of Cancer Survivors |
|
Trends in primary central nervous system lymphoma incidence and survival in the U.S. |
|
Variation in effects of non-Hodgkin lymphoma risk factors according to the human leukocyte antigen (HLA)-DRB1*01:01 allele and ancestral haplotype 8.1 |
|
Variations in chromosomes 9 and 6p21.3 with risk of non-Hodgkin lymphoma |
|
Within-host competition and drug resistance in the human malaria parasite Plasmodium falciparum. |
|